Figures & data
Table 1. Primary and secondary MIBC patients treated with curative intent: (a) All patients: Patient- and treatment characteristics, (b) Patients treated with radical cystectomy (RC): pT-category, (c) Patients treated with RC: pN-category (d) Patients treated with RC: Concomitant CIS.
Figure 1. Survival after diagnosis of MIBC in 650 patients undergoing curative treatment: (a) All patients; Crude overall survival (OS = dashed) and cancer-specific survival (CSS = solid), (b) CSS in all patients; primary (priMIBC = solid) vs. secondary MIBC (secMIBC = dashed), (c) CSS in patients treated with radical cystectomy (RC); primary vs. secondary MIBC, (d) CSS in patients treated with radiotherapy (RT); primary vs. secondary MIBC.
Table 2. Flexible parametric survival model evaluating associations with cancer-specific survival for all included MIBC patients (N = 650).
Figure 2. Adjusted difference in cancer-specific survival between patient with primary and secondary MIBC by treatment; no difference (dashed), observed survival difference (solid), confidence interval (CI = grey area); (a) All patients, both types of curative intent treatment, (b) Post-cystectomy (RC), (c) Post-radiotherapy (RT).
